Patents by Inventor Jordan Devereaux

Jordan Devereaux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SECOND GENERATION INHIBITORS OF MITOCHONDRIAL PERMEABILITY TRANSITION PORE WITH IMPROVED PLASMA STABILITY
    Publication number: 20220289690
    Abstract: The present invention provides compounds useful as mitochondrial permeability transition pore (mtPTP) inhibitors, the compounds being of Formula (I), or a pharmaceutically acceptable salt thereof wherein R1 is selected from the group of H, halogen, and C1-C3 alkyl; and R2 is selected from the group of H, CF3, and halogen; with the proviso that at least one of R1 and R2 is halogen or CF3.
    Type: Application
    Filed: July 24, 2020
    Publication date: September 15, 2022
    Applicant: Oregon Health & Science University
    Inventors: Michael Cohen, Michael Forte, Justina Sileikyte, Aaron Nilsen, Jordan Devereaux, Paolo Bernardi
  • Derivatives of sobetirome
    Patent number: 10870616
    Abstract: Disclosed are halo substituted derivative compounds of sobetirome with improved pharmacological characteristics relative to sobetirome, pharmaceutical compositions that include those compounds and methods of treating diseases such as neurodegenerative disorders using those pharmaceutical compositions.
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: December 22, 2020
    Assignee: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas Scanlan, Jordan Devereaux, Andrew Placzek, Tapasree Banerji, Skylar Ferrara, James Matthew Meinig, Tania Banerji
  • DERIVATIVES OF SOBETIROME
    Publication number: 20200325092
    Abstract: Disclosed are halo substituted derivative compounds of sobetirome with improved pharmacological characteristics relative to sobetirome, pharmaceutical compositions that include those compounds and methods of treating diseases such as neurodegenerative disorders using those pharmaceutical compositions.
    Type: Application
    Filed: December 9, 2019
    Publication date: October 15, 2020
    Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas SCANLAN, Jordan DEVEREAUX, Andrew PLACZEK, Tapasree BANERJI, Skylar FERRARA, James Matthew MEINIG, Tania BANERJI
  • Derivatives of sobetirome
    Patent number: 10544075
    Abstract: Disclosed are halo substituted derivative compounds of sobetirome with improved pharmacological characteristics relative to sobetirome, pharmaceutical compositions that include those compounds and methods of treating diseases such as neurodegenerative disorders using those pharmaceutical compositions.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: January 28, 2020
    Assignee: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas Scanlan, Jordan Devereaux, Andrew Placzek, Tapasree Banerji, Skylar Ferrara, James Matthew Meinig, Tania Banerji